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Abstract 
Introduction: The overexpression of P-gp in cancer tumor cells result in increased 
efflux of chemotherapeutic compounds. This phenomenon leads tothe wide-
spectrum resistance of cancer cells to variant drugs or multi drug resistance (MDR). 
Regarding the important biological role of P-gp with regard to cancer therapy, in 
silico analysis of binding affinity/mode of diverse anticancer drugs toward P-gp may 
be an active area of research since it provides more insight into the binding 
interactions and key amino acid residues that were involved. 
Methods and Results:Ligand-flexible docking studies were performed using the 
molecular docking software, AutoDock 4.2. To elucidate the interactions of selected 
anticancer drugs, all the related structures were docked into the active site of 
validated P-gptarget (4XWK). Quantum mechanical calculations were applied to 
intermolecular binding energy analysis in terms of drug-residue binding interactions 
via functional B3LYP in association with split valence basis set using polarization 
functions (Def2-SVP). 
Mitomycin was found to be the weakest binder with -7.29 kcal/mol energy. 
Bisantrenewas the top-ranked binder(-10.59 kcal/mol)with H-bond and lipophilic 
interaction patterns. To explain more, Asn838 participated in bidentate H-bonding 
with nitrogen atom of imidazole ring. Another H-bond interaction was detected in 
the case of Ser725 within the same ring but different nitrogen atom of the drug 
molecule. Besides hydrogen bonding, it was revealed that 12 hydrophobic residues 
interacted with Bisantrene. Within the evaluated drugs, unlike EpothiloneE and F, no 
H-bondscould be detected for Epothilone A, B, C& D. Such observation was 
pertained to the presence of hydroxymethyl moiety on the thiazole ring of 
EpothiloneE and F which provided well-oriented H-bonds with Ala307. Despite 
observed interactive residues, lower binding affinity of Epothilone F persuaded us to 
run QM job in terms ofdrug-residue binding interactions. It was interestingly 
concluded that a few residues made repulsive forces with the drug, a result that 
might explain lower affinity of this molecule toward P-gp. 
Conclusions:Collective in silico exploration of a few anticancer drugs provided 
some insights into the binding mode toward P-gp as an interfering target in 
chemotherapeutic strategies. On the basis of obtained results, structure binding 
relationship pattern for studied anticancer drugs were developed. 
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